Jana Polivkova

Person

Ledyard, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for antagonizing a melanocortin 4 receptor
- Patent number 12,187,727
- Issue date Jan 7, 2025
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diacylglycerol acyl transferase 2 inhibitors
- Patent number 11,866,425
- Issue date Jan 9, 2024
- Pfizer Inc.
- Markus Boehm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Melanocortin 4 receptor antagonists and uses thereof
- Patent number 11,643,412
- Issue date May 9, 2023
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diacylglycerol acyl transferase 2 inhibitors
- Patent number 11,034,678
- Issue date Jun 15, 2021
- Pfizer Inc.
- Markus Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diacylglycerol acyl transferase 2 inhibitors
- Patent number 10,071,992
- Issue date Sep 11, 2018
- Pfizer Inc.
- Markus Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of prostaglandin EP3 receptor
- Patent number 9,738,626
- Issue date Aug 22, 2017
- Pfizer Inc.
- Kevin Bahnck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(indole-2-carbonyl) and H-thieno[2,3-b]pyrrole-5-carboxamide anti...
- Patent number 6,992,101
- Issue date Jan 31, 2006
- Pfizer, Inc.
- Donald L. Bussolotti
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Diacylglycerol Acyl Transferase 2 Inhibitors
- Publication number 20240140937
- Publication date May 2, 2024
- Pfizer Inc.
- Markus Boehm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ANTAGONIZING A MELANOCORTIN 4 RECEPTOR
- Publication number 20230174532
- Publication date Jun 8, 2023
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20230019853
- Publication date Jan 19, 2023
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
- Publication number 20210309646
- Publication date Oct 7, 2021
- Pfizer Inc.
- Markus Boehm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
- Publication number 20200181127
- Publication date Jun 11, 2020
- Pfizer Inc.
- Markus Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
- Publication number 20180258081
- Publication date Sep 13, 2018
- Pfizer Inc.
- Markus Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
- Publication number 20180051012
- Publication date Feb 22, 2018
- Pfizer Inc.
- Markus Boehm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR
- Publication number 20160176851
- Publication date Jun 23, 2016
- Pfizer Inc.
- Kevin Bahnck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-diabetic agents
- Publication number 20040157907
- Publication date Aug 12, 2004
- Pfizer Inc.
- Donald L. Bussolotti
- C07 - ORGANIC CHEMISTRY

Jana Polivkova

Person

Patents Grantslast 30 patents

Methods for antagonizing a melanocortin 4 receptor

Diacylglycerol acyl transferase 2 inhibitors

Melanocortin 4 receptor antagonists and uses thereof

Diacylglycerol acyl transferase 2 inhibitors

Diacylglycerol acyl transferase 2 inhibitors

Antagonists of prostaglandin EP3 receptor

N-(indole-2-carbonyl) and H-thieno[2,3-b]pyrrole-5-carboxamide anti...

Patents Applicationslast 30 patents

Diacylglycerol Acyl Transferase 2 Inhibitors

METHODS FOR ANTAGONIZING A MELANOCORTIN 4 RECEPTOR

MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF

DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS

DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS

DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS

DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS

ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR

Anti-diabetic agents